Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2016-01-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects
NCT03798262
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
NCT04243551
Wheat Bread Study: Comparison of the Tolerance of Different Wheat Breads
NCT06152445
Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity
NCT03798249
Immunologic Basis of Food Protein-Induced Enterocolitis Syndrome
NCT06683521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Milk
Acute ingestion of 20 g milk protein
Mycoprotein ingestion
20g
Acute ingestion of 20 g mycoprotein
Mycoprotein ingestion
40g
Acute ingestion of 40 g mycoprotein
Mycoprotein ingestion
60g
Acute ingestion of 60 g mycoprotein
Mycoprotein ingestion
80g
Acute ingestion of 60 g mycoprotein
Mycoprotein ingestion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mycoprotein ingestion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 18 and 30
Exclusion Criteria
* Family history of metabolic disease
* Diagnosed with any metabolic or cardiovascular conditions
* BMI \< 18 or \> 30
18 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Exeter
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin T Wall, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Exeter, College of Life and Environmental Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sport & Health Sciences
Exeter, Devon, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
157758
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.